Duvelisib, a new PI3K inhibitor for lymphoid malignancies

Clin Adv Hematol Oncol. 2020 Oct;18(10):606-608.
No abstract available

Publication types

  • Interview

MeSH terms

  • Hematologic Neoplasms / drug therapy*
  • Humans
  • Isoquinolines / therapeutic use*
  • Lymphoproliferative Disorders / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Purines / therapeutic use*

Substances

  • Isoquinolines
  • Protein Kinase Inhibitors
  • Purines
  • duvelisib